Last reviewed · How we verify
hyaluronic acid and chondroitin sulphate
At a glance
| Generic name | hyaluronic acid and chondroitin sulphate |
|---|---|
| Also known as | IALURIL® |
| Sponsor | Samsung Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Early vs Delayed Intravesical Blad-Care During BCG Therapy (NA)
- "Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy" (NA)
- Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (PHASE4)
- Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (PHASE1)
- Long-Term Effects of Mobithron Advance on Knee Osteoarthritis Aims to Investigate the Effects of Mobithron Advance on OA Progression (EARLY_PHASE1)
- Efficacy of Hyaluronic Acid Injections on Functional Recovery After Surgery for Prostate Adenoma (NA)
- Single-Dose Hybrid Hyaluronic Acid and Sodium Chondroitin with Rehabilitation for Sports Adults with Knee Osteoarthritis
- Alternative Prophylaxis in Female Recurrent Urinary Tract Infections (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: